Table 1 30-year cancer specific and overall cumulative survival for patients undergoing adjuvant radiotherapy and chemotherapy with primary operable breast cancer, n = 322
From: Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival
| Â | Cancer-specific survival | p-value | Overall survival | p-value |
|---|---|---|---|---|
Age | Â | Â | Â | Â |
≤50 years | 40 (5) | 0.023 | 31 (2) | 0.001 |
>50 years | 28 (3) | Â | 12 (2) | Â |
Socio-economic circumstances | Â | Â | Â | Â |
Affluent (DEPCATs 1-2) | 41 (6) | Â | 24 (5) | Â |
Intermediate (DEPCATs 3-5) | 33 (4) | 0.657 | 19 (3) | 0.784 |
Deprived (DEPCATs 6-7) | 27 (5) | Â | 14 (4) | Â |
Menopausal status | Â | Â | Â | Â |
Pre | 39 (4) | 0.071 | 30 (4) | 0.002 |
Post | 29 (4) | Â | 12 (2) | Â |
Involved lymph node | Â | Â | Â | Â |
≤3 | 38 (4) | <0.001 | 21 (3) | <0.001 |
>3 | 23 (4) | Â | 14 (3) | Â |
Hormonal-receptor status | Â | Â | Â | Â |
ER+ | 33 (5) | 0.052 | 17 (4) | 0.055 |
ER- | 31 (5) | Â | 17 (4) | Â |